We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $1.21T
1-Year Est. Return 78.12%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+33.53%
1 Year Est. Return
+78.12%
3 Year Est. Return
+206.85%
5 Year Est. Return
+219.98%
10 Year Est. Return
+787.7%
AUM
$1.21T
AUM Growth
+$428B
Cap. Flow
+$44.4B
Cap. Flow %
3.68%
Top 10 Hldgs %
32.48%
Holding
13,869
New
2,565
Increased
4,995
Reduced
3,730
Closed
2,484

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$1.75B
2
AVGO icon
Broadcom
AVGO
+$1.56B
3
DELL icon
Dell
DELL
+$1.09B
4
SNDK
Sandisk
SNDK
+$899M
5
TMUS icon
T-Mobile US
TMUS
+$827M

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.39%
2 Technology 3.64%
3 Industrials 1.09%
4 Consumer Discretionary 0.89%
5 Financials 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
11351
CALL
Arbutus Biopharma
ABUS
$1.01B
-33,000
Closed -$149K
ABUS icon
11352
PUT
Arbutus Biopharma
ABUS
$1.01B
-25,500
Closed -$115K
ABVC icon
11353
CALL
ABVC BioPharma
ABVC
$26.1M
-10,700
Closed -$10.4K
ACAD icon
11354
PUT
Acadia Pharmaceuticals
ACAD
$4.74B
-39,100
Closed -$870K
ACB
11355
PUT
Aurora Cannabis
ACB
$237M
-17,300
Closed -$56.6K
ACHR icon
11356
Archer Aviation
ACHR
$4.24B
-1,116,648
Closed -$6.49M
ACIC icon
11357
CALL
American Coastal Insurance
ACIC
$442M
-37,300
Closed -$420K
ACIC icon
11358
PUT
American Coastal Insurance
ACIC
$442M
-92,700
Closed -$1.04M
ACLX
11359
CALL
DELISTED
Arcellx
ACLX
-23,000
Closed -$2.64M
ACLX
11360
PUT
DELISTED
Arcellx
ACLX
-30,800
Closed -$3.54M
ACNB icon
11361
ACNB Corp
ACNB
$661M
-11,012
Closed -$527K
ACRE
11362
Ares Commercial Real Estate
ACRE
$240M
-22,316
Closed -$110K
ACT icon
11363
CALL
Enact Holdings
ACT
$6.8B
-5,400
Closed -$220K
ACVA icon
11364
CALL
ACV Auctions
ACVA
$1.77B
-85,900
Closed -$364K
ADCT icon
11365
CALL
ADC Therapeutics
ADCT
$137M
-12,700
Closed -$47.6K
ADSE icon
11366
PUT
ADS-TEC Energy
ADSE
$871M
-10,000
Closed -$115K
ADSK icon
11367
Autodesk
ADSK
$47.8B
-5,888
Closed -$1.34M
ADT icon
11368
PUT
ADT
ADT
$5.17B
-25,000
Closed -$164K
ADUS icon
11369
Addus HomeCare
ADUS
$2.19B
-23,019
Closed -$2.17M
ADV icon
11370
Advantage Solutions
ADV
$427M
-12,677
Closed -$268K
ADX icon
11371
Adams Diversified Equity Fund
ADX
$3.22B
-26,898
Closed -$589K
AEON icon
11372
AEON Biopharma
AEON
$14.3M
-16,376
Closed -$16.1K
AERT
11373
Aeries Technology
AERT
$36.9M
-8,867
Closed -$22.2K
AETH icon
11374
Bitwise Ethereum Strategy
AETH
$6.89M
-24,373
Closed -$832K
AFG icon
11375
PUT
American Financial Group
AFG
$11.8B
-5,800
Closed -$741K

Similar funds

Jane Street's Q2 2026 Portfolio in Review

As of Q2 2026, Jane Street held 13,869 positions worth $1.21T, up 55% from $777B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jane Street deployed $44.4B of net new capital in Q2 2026, opening 2,565 new positions and adding to 4,995 existing holdings. Its largest new stake was Super Micro Computer Depositary Shares 7% Series A Preferred Stock: 10,590,097 shares worth $550M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Marvell Technology, an estimated $1.75B trimmed.

  • Jane Street's largest Q2 2026 buy was Super Micro Computer Depositary Shares 7% Series A Preferred Stock: 10,590,097 shares worth $550M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $17.4B increase.
  • Jane Street's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.75B.
  • Jane Street fully exited iShares Core US Aggregate Bond ETF in Q2 2026, selling an estimated $239M.
  • Jane Street's ten largest holdings make up 32% of its $1.21T portfolio in Q2 2026.
  • Jane Street opened 2,565 new positions and closed 2,484 in Q2 2026.
  • Jane Street's portfolio value rose 55% quarter-over-quarter to $1.21T.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.